Literature DB >> 8305881

A four-year longitudinal study of bone loss in patients with inflammatory bowel disease.

R J Motley1, D Clements, W D Evans, E O Crawley, C Evans, J Rhodes, J E Compston.   

Abstract

Serial measurements of spinal trabecular and radial cortical bone density were made over 4 years in 70 patients with inflammatory bowel disease. Mean rates of bone loss for the cohort differed little from rates reported in normal populations; however, some patients showed increased rates of loss, including patients whose bone density at entry to the study was already well below normal. There was a significant correlation between the amount of corticosteroid prescribed and spinal trabecular bone loss in males, but no significant correlation with other clinical parameters. Increased rates of bone loss emphasise the need for bone densitometry and prophylactic measures in patients with inflammatory bowel disease.

Entities:  

Mesh:

Year:  1993        PMID: 8305881     DOI: 10.1016/s0169-6009(08)80046-3

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  13 in total

Review 1.  Bone abnormalities in gastrointestinal and hepatic disease.

Authors:  F A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Longitudinal study of bone mineral density in patients with Crohn's disease.

Authors:  D J de Jong; L Mannaerts; L G M van Rossum; F H M Corstens; A H J Naber
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

3.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 4.  Extraintestinal manifestations of inflammatory bowel disease.

Authors:  Folashade A Jose; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-02       Impact factor: 2.839

Review 5.  Extraintestinal manifestations and complications in inflammatory bowel diseases.

Authors:  Katja S Rothfuss; Eduard F Stange; Klaus R Herrlinger
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

6.  Inflammatory bowel disease and predisposition to osteopenia.

Authors:  F J Cowan; J T Warner; F D Dunstan; W D Evans; J W Gregory; H R Jenkins
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

7.  High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease.

Authors:  J Klaus; G Armbrecht; M Steinkamp; J Brückel; A Rieber; G Adler; M Reinshagen; D Felsenberg; C von Tirpitz
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

8.  High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease.

Authors:  A Kuwabara; K Tanaka; N Tsugawa; H Nakase; H Tsuji; K Shide; M Kamao; T Chiba; N Inagaki; T Okano; S Kido
Journal:  Osteoporos Int       Date:  2008-09-30       Impact factor: 4.507

9.  Metaphyseal and diaphyseal bone loss in the tibia following transient muscle paralysis are spatiotemporally distinct resorption events.

Authors:  Brandon J Ausk; Philippe Huber; Sundar Srinivasan; Steven D Bain; Ronald Y Kwon; Erin A McNamara; Sandra L Poliachik; Christian L Sybrowsky; Ted S Gross
Journal:  Bone       Date:  2013-09-21       Impact factor: 4.398

10.  Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.

Authors:  J Kjeldsen; O B Schaffalitzky de Muckadell; P Junker
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.